MetaCap

Lyell Immunopharma Statistics

NASDAQ: LYELHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.80+0.22 (+1.62%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Lyell Immunopharma by the numbers

Lyell Immunopharma has a market capitalization of $441.8 million based on 32.02M shares outstanding. With trailing EPS of $-12.61, Lyell Immunopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.6% above its 50-day average and 14.4% below its 200-day average.

Average daily trading volume is 174.76K shares, or about $2.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

LYEL valuation vs. peer median

LYEL compared with the median of 8 peer companies
MetricLYELPeer medianDifference
Market cap$441.82M$438.09M+1%
Avg. volume174.76K887.14K-80%

Peer median across 8 companies: AQST, INDP, EOLS, CAPR, CTMX, AMRN, DMAC, ARVN.

Valuation

Market cap
$441.82M
Price / sales (latest FY)
12,272.69
EPS (TTM)
$-12.61

Price and trading

Previous close
13.58
Open
13.36
Day range
13.30 – 14.30
52-week range
7.20 – 45.00
52-week change
-27.86%
Beta
—
Volume
171.09K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
441.82M
Forward Pe
-2.34
Eps
-12.61
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
45.00
Week52 Low
7.20
Avg Volume
174.76K
Shares Outstanding
32.02M
Ma50
11.08
Ma200
16.12
Earnings Date
Nov 4, 2026
Pct From52w High
-69.33%
Pct From52w Low
91.80%

Related